WINNIPEG, May 10, 2013 /CNW/ - Medicure Inc. (the "Company") (TSX VENTURE:MPH)(PINKSHEETS:MCUJD) announces today that the Board of Directors has approved the grant of an aggregate of 463,000 options to certain directors, officers, employees, management company employees and consultants of the Company pursuant to the Company's Stock Option Plan. These options entitle the holders thereof to acquire, on or before the tenth anniversary of the date of grant, up to 463,000 common shares of the Company at an exercise price of $0.30 per share. The options are subject to the approval of the TSX Venture Exchange. In accordance with securities regulatory requirements, any shares issued pursuant to the exercise of such options will be subject to a resale restriction for a period of four months from the date of grant of the underlying option.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.